Lecture

Growth Hormone: Physiology and Pathologies

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

In course

BIO-321: Morphology II

Ce cours permet aux étudiants ayant suivi Morphologie I de réviser et d'approfondir leurs connaissances par l'étude de l'anatomie radiologique et du développement. L'origine de malformations fréquentes est décrite. Divers sujets requis pour l'examen d'entr ...

Description

This lecture covers the physiology of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), including their mode of action, metabolic effects, and circadian rhythm of secretion. It also discusses the pathologies associated with GH, such as acromegaly, gigantism, and various types of dwarfism. The instructor explains the clinical evaluation of the hypothalamic-pituitary-hepatic axis and the synthesis and secretion of GH. Additionally, the lecture delves into the effects of GH on bone and tissue growth, as well as the different mutations and disorders linked to GH and IGF-1. Optical microscopy images of the pituitary gland and the major cell types in the anterior pituitary are also presented.

Instructor

Romain Zufferey

Teaching & PhD Courses Biology for engineers MSE-212 This course consists of an introduction to biology and more particularly to biology as a multidisciplinary field, emphasizing natural examples of materials engineering. It should therefore allow engineering students to find inspiration from biology in future materials research problems. Cellular biology and biochemistry for engineers BIO-105 Basic course in biochemistry as well as cellular and molecular biology for non-life

Official source

Ontological neighbourhood

Health sciences

Endocrinology: Topics in endocrinology

Related concepts (32)

Gigantism

Gigantism (γίγας, gígas, "giant", plural γίγαντες, gígantes), also known as giantism, is a condition characterized by excessive growth and height significantly above average. In humans, this condition is caused by over-production of growth hormone in childhood, resulting in people up to in height. It is a rare disorder resulting from increased levels of growth hormone before the fusion of the growth plate which usually occurs at some point soon after puberty. This increase is most often due to abnormal tumor growths on the pituitary gland.

Circadian rhythm

A circadian rhythm (sərˈkeɪdiən), or circadian cycle, is a natural oscillation that repeats roughly every 24 hours. Circadian rhythms can refer to any process that originates within an organism (i.e., endogenous) and responds to the environment (is entrained by the environment). Circadian rhythms are regulated by a circadian clock whose primary function is to rhythmically co-ordinate biological processes so they occur at the correct time to maximise the fitness of an individual.

Growth hormone therapy

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

Growth hormone–releasing hormone

Growth hormone–releasing hormone (GHRH), also known as somatocrinin or by several other names in its endogenous forms and as somatorelin (INN) in its pharmaceutical form, is a releasing hormone of growth hormone (GH). It is a 44-amino acid peptide hormone produced in the arcuate nucleus of the hypothalamus. GHRH first appears in the human hypothalamus between 18 and 29 weeks of gestation, which corresponds to the start of production of growth hormone and other somatotropes in fetuses.

Pituitary adenoma

Pituitary adenomas are tumors that occur in the pituitary gland. Most pituitary tumors are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%. Non-invasive and non-secreting pituitary adenomas are considered to be benign in the literal as well as the clinical sense; however a recent meta-analysis (Fernández-Balsells, et al.

Related lectures (46)

Growth Hormone Regulation: Physiology and Signaling

Explores the regulation and signaling of growth hormone, including physiological effects and intracellular pathways.

Differential Interference Contrast Microscopy

Explores Differential Interference Contrast microscopy, explaining its principles, equipment, image interpretation, and comparison with phase contrast microscopy.

Growth Hormone and Receptor: Mechanisms and Effects

Explores dwarfism types, growth hormone action, and JAK-STAT pathway signaling.

Scanning Probe Microscopy: Fundamentals and Applications

Explores the fundamentals and applications of scanning probe microscopy, including STM setup, surface reconstruction, quantum tunneling, and scanning force microscopy.

Histology Practice: Hypophysis Microscopy